CD8+ Tregs are significantly reduced in patients with SS, however in the late stage of SS, the number of CD8+ Tregs cells tends to increase, which inhibits the activation of dendritic cells and reduces the number of CD4+ Tfh cells. This evidence concerns the gene CD4 and synovial sarcoma.